The Future of Drug Delivery: From Infusion Centers to Wearable Biologics | Matthew Huddleston - Chief Commercial Officer, Enable Injections

Send us Fan MailSome of the most important cancer and autoimmune disease drugs in the world still require patients to sit in infusion chairs for hours - but that model may be about to change entirely.Matthew Huddleston is Chief Commercial Officer at Enable Injections ( https://enableinjections.com/ ), a medical device company focused on rethinking how large-volume biologic drugs are delivered to patients.Enable’s core technology, the enFuse® on-body delivery system, is designed to shift certain therapies from traditional intravenous infusion to subcutaneous, wearable administration - potentially transforming treatment from something that requires a clinic visit into something that can be done at home, more comfortably and more conveniently.What makes this particularly interesting is where Enable sits in the broader biopharma ecosystem. The company is actively partnering with major pharmaceutical innovators including Sanofi, Roche, Incyte, and Viridian Therapeutics to support the transition of complex biologics into subcutaneous delivery formats.One of the clearest signals of momentum is that Sanofi’s Sarclisa combined with Enable’s on-body injector has been recommended for approval in Europe by the CHMP, with FDA review ongoing - highlighting that this is no longer theoretical innovation, but an emerging commercial pathway.Enable is also extending its platform through collaboration with Aptar Pharma and its digital health division, integrating companion software to support patients throughout therapy - bringing drug delivery closer to a connected care ecosystem, where device, data, and treatment adherence increasingly converge.On this episode we will unpack how this platform works, what it enables for pharma partners, and how wearable drug delivery could reshape the future of biologics.#biotech #medtech #drugdelivery #biologics #pharma #oncology #multiplemyeloma #medicaldevices #healthtech #wearabletech #subcutaneous #infusiontherapy #drugdevelopment #pharmaceuticalindustry #innovation #digitalhealth #enableinjections #sanofi #roche #incyte #clinicaltrialsSupport the show